Novo Holdings increases stakes on German Novo partner – adds EUR 50m investment

German Evotec has raised DKK 1.9bn (EUR 255m), out of which the EUR 50m stem from Novo Holdings, by which the latter increases its stakes in the biotech and contract research firm, which recently started its partnership with Novo Nordisk in chronic kidney diseases.

Photo: Novo Holdings / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles